Catalyst Wire Dossier Catalyst Wire Dossier

COVID-HIG

· Emergent BioSolutions
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for COVID-HIG, covering 2022-01-03 to 2024-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults [Phase 1]

See pricing